Dopamine Receptor Availability in ADHD

J Gordon Millichap

doi:10.15844/pedneurbriefs-16-1-10

Dopamine Receptor Availability in ADHD

Pediatric Neurology Briefs

Volume 16 (2002): Issue 1

By: J Gordon Millichap

Open Access

|Jan 2002

Abstract

Striatal dopamine (D2) receptor availability was determined by iodobenzamide brain SPECT, before and 3 months after methylphenidate (MPH) therapy, in 9 children (mean age, 9.8 years) with attention deficit hyperactivity disorder (ADHD) examined at Gazi University, Ankara, Turkey.

References

Ilgin N Senol S Gucuyener K Gokcora N Sener S Is increased D2 receptor availability associated with response to stimulant medication in ADHD Dev Med Child Neurol 2001 Nov 43 11 755 60 10.1111/j.1469-8749.2001.tb00157.x 11730150
Open DOI Search in Google Scholar Back to article
Millichap JG Drugs in management of minimal brain dysfunction Ann N Y Acad Sci 1973 Feb 28 205 321 34 10.1111/j.1749-6632.1973.tb43189.x 4144050
Open DOI Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.15844/pedneurbriefs-16-1-10 | Journal eISSN: 2166-6482

Journal RSS Feed

Language: English

Page range: 7 - 7

Published on: Jan 1, 2002

Published by: Pediatric Neurology Briefs Publishers

In partnership with: Paradigm Publishing Services

Keywords:

Striatal Dopamine,

Methylphenidate,

Attention Deficit Hyperactivity Disorder

© 2002 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.

Volume 16 (2002): Issue 1